…
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials. The company also provides T-FIT, a clean insulation system; and ReZorce circular packaging, a range of mono-material barrier packaging solution. In addition, it owns and licenses microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aviation, medical, product protection, industrial, marine, building and construction, sports and leisure, military, athletic footwear, food and personal care manufacturing, pharmaceutical, biotech, semiconductor cleanroom, and consumer packaging industries. Zotefoams plc was founded in 1921 and is headquartered in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 19.96M | 0.15M | 12.84M | 12.22M | 7.01M |
| Net income | 22.64M | -2.75M | 9.24M | 10.01M | 4.38M |
| Selling general administrative | - | 19.52M | 17.99M | 16.76M | 11.12M |
| Selling and marketing expenses | - | 8.48M | 7.93M | 8.04M | 7.32M |
| Gross profit | 52.90M | 46.13M | 41.05M | 38.73M | 26.57M |
| Reconciled depreciation | - | 8.98M | 8.22M | 8.24M | 7.62M |
| Ebit | 22.57M | 3.30M | 15.19M | 13.93M | 8.13M |
| Ebitda | 31.26M | 12.28M | 23.41M | 22.28M | 15.75M |
| Depreciation and amortization | 8.69M | 8.98M | 8.22M | 8.35M | 7.62M |
| Operating income | 22.57M | 2.95M | 15.13M | 13.93M | 8.13M |
| Other operating expenses | 135.92M | 144.84M | 111.84M | 113.44M | 92.62M |
| Interest expense | 1.96M | 3.15M | 2.54M | 1.81M | 1.12M |
| Tax provision | - | 2.91M | 3.60M | 2.22M | 2.63M |
| Interest income | - | 0.27M | 0.19M | 0.06M | 0.01M |
| Net interest income | - | -2.87M | -2.35M | -1.76M | -1.10M |
| Income tax expense | -2.68M | 2.91M | 3.60M | 2.22M | 2.63M |
| Total revenue | 158.49M | 147.79M | 126.97M | 127.37M | 100.75M |
| Total operating expenses | 30.33M | 43.18M | 25.92M | 24.80M | 18.43M |
| Cost of revenue | 105.59M | 101.66M | 85.92M | 88.64M | 74.18M |
| Total other income expense net | -2.61M | -2.80M | -2.29M | -1.71M | -1.12M |
| Net income from continuing ops | - | -2.75M | 9.24M | 10.01M | 4.38M |
| Net income applicable to common shares | - | - | - | - | 4.38M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 227.09M | 174.75M | 175.61M | 170.36M | 157.91M |
| Intangible assets | - | 7.67M | 7.02M | 5.25M | 3.97M |
| Other current assets | 0.98M | 0.04M | 1.26M | 29.93M | 24.51M |
| Total liab | 97.02M | 65.39M | 59.85M | 60.82M | 60.14M |
| Total stockholder equity | 130.08M | 109.36M | 115.76M | 109.54M | 97.78M |
| Deferred long term liab | - | - | - | 2.38M | 1.09M |
| Other current liab | 7.87M | 8.71M | 7.74M | 1.78M | 0.68M |
| Common stock | 2.46M | 2.44M | 2.44M | 2.43M | 2.43M |
| Capital stock | - | 2.44M | 2.44M | 2.43M | 2.43M |
| Retained earnings | 80.69M | 59.76M | 64.46M | 57.30M | 49.24M |
| Other liab | - | - | - | - | 7.81M |
| Good will | - | 0.00M | 2.40M | 2.53M | 2.25M |
| Other assets | - | - | - | - | 0.50M |
| Cash | 13.98M | 10.53M | 6.29M | 10.59M | 8.05M |
| Total current liabilities | 77.74M | 51.92M | 51.09M | 53.23M | 36.98M |
| Current deferred revenue | - | - | 1.08M | - | - |
| Net debt | 43.03M | 33.02M | 31.57M | 27.82M | 34.35M |
| Short term debt | 48.28M | 36.74M | 37.03M | 37.95M | 27.05M |
| Short long term debt | - | 34.60M | 36.53M | 37.45M | 26.56M |
| Short long term debt total | 57.01M | 43.56M | 37.86M | 38.41M | 42.40M |
| Other stockholder equity | 44.16M | 44.17M | 44.17M | 49.81M | 46.10M |
| Property plant equipment | - | - | - | - | 92.50M |
| Total current assets | 78.94M | 71.99M | 72.46M | 66.67M | 58.52M |
| Net tangible assets | - | - | - | - | 91.55M |
| Short term investments | - | - | 0.07M | - | - |
| Net receivables | 36.71M | 31.49M | 33.00M | 29.45M | 24.34M |
| Long term debt | - | - | - | 0.00M | 14.71M |
| Inventory | 27.27M | 29.92M | 31.90M | 26.14M | 25.95M |
| Accounts payable | 21.58M | 4.97M | 5.25M | 13.50M | 9.24M |
| Accumulated other comprehensive income | 2.77M | 2.98M | 4.70M | - | - |
| Non currrent assets other | - | 0.01M | 0.07M | 0.28M | 0.17M |
| Non current assets total | 148.15M | 102.75M | 103.14M | 103.69M | 99.39M |
| Capital lease obligations | - | 8.96M | 1.33M | 0.96M | 1.13M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -13.34M | -8.29M | -7.04M | -7.00M |
| Change to liabilities | - | - | - | 0.00M | 1.51M |
| Total cashflows from investing activities | -36.93M | -13.34M | -8.29M | - | -7.00M |
| Net borrowings | - | -1.61M | 0.38M | - | -1.31M |
| Total cash from financing activities | 4.92M | -7.41M | -3.73M | -11.53M | -4.34M |
| Change to operating activities | - | - | - | - | -0.78M |
| Net income | 22.64M | -2.75M | 9.24M | 10.01M | 4.38M |
| Change in cash | 3.45M | 4.24M | -4.30M | 2.54M | -0.45M |
| Begin period cash flow | 10.53M | 6.29M | 10.59M | 8.05M | 8.50M |
| End period cash flow | 13.98M | 10.53M | 6.29M | 10.59M | 8.05M |
| Total cash from operating activities | 35.50M | 25.00M | 7.78M | 21.07M | 10.92M |
| Issuance of capital stock | - | 0.07M | 0.00M | 0.00M | 0.04M |
| Depreciation | 8.69M | 8.98M | 8.22M | 8.24M | 7.62M |
| Other cashflows from investing activities | - | -2.99M | -2.55M | 0.06M | -0.02M |
| Dividends paid | 3.71M | 3.54M | 3.35M | 3.19M | 3.07M |
| Change to inventory | 4.54M | 1.95M | -6.28M | 0.40M | -2.84M |
| Change to account receivables | -1.59M | 1.54M | -3.77M | -4.82M | -1.64M |
| Other cashflows from financing activities | -2.74M | -2.33M | -0.75M | 42.55M | 6.43M |
| Change to netincome | - | - | - | 3.97M | 2.67M |
| Capital expenditures | 13.96M | 13.65M | 8.48M | 7.09M | 7.07M |
| Change in working capital | 6.56M | 2.49M | -11.08M | -0.30M | -2.97M |
| Stock based compensation | - | 1.08M | 1.33M | 0.81M | 0.36M |
| Other non cash items | -2.38M | 15.21M | 0.07M | 2.31M | 1.10M |
| Free cash flow | 21.54M | 11.35M | -0.70M | 13.98M | 3.85M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ZTF Zotefoams PLC |
-5.00 1.03% |
481.50 | 8.44 | 9.40 | 1.17 | 1.35 | 1.38 | 7.06 |
| CRDA Croda International PLC |
19.00 0.53% |
3628.00 | 68.18 | 16.64 | 2.46 | 1.83 | 2.67 | 17.69 |
| JMAT Johnson Matthey PLC |
4.00 0.16% |
2466.00 | - | 9.44 | 0.29 | 1.53 | 0.36 | 10.76 |
| ELM Elementis PLC |
3.40 1.87% |
185.00 | 19.70 | 15.15 | 1.50 | 1.79 | 2.27 | 9.68 |
| 87FZ AECI Ltd |
-65.09 99.00% |
0.66 | 0.01 | - | 0.02 | - | - | - |
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials. The company also provides T-FIT, a clean insulation system; and ReZorce circular packaging, a range of mono-material barrier packaging solution. In addition, it owns and licenses microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aviation, medical, product protection, industrial, marine, building and construction, sports and leisure, military, athletic footwear, food and personal care manufacturing, pharmaceutical, biotech, semiconductor cleanroom, and consumer packaging industries. Zotefoams plc was founded in 1921 and is headquartered in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. David B. Stirling B.Sc., BSC CA, C.A., M.B.A., M.Sc., MBA, MSC | Group CEO, MD & Exec. Director | 1967 |
| Mr. Gary C. McGrath | Group CFO & Exec. Director | NA |
| Mr. Benito Sala | Managing Director of Europe, UK | NA |
| Lydia Harratt | Company Sec. | NA |
| Mr. Ronan Michael Cox | Group CEO & Executive Director | 1973 |
| Mr. Nicholas James Wright | CFO & Executive Director | 1976 |
| Ms. Clare Farmer | Chief People Officer | NA |
| Mr. Hugh Morgan | Managing Director of Footwear | NA |
| Mr. Simon Jones | Managing Director of EMEA | NA |
| Mr. Dan Lumpkin | Managing Director of North America | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.